Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 231.38%28.4B | -2.49%8.66B | 0 | 0 | -26.79B | 8.57B | 8.88B | 0 | 0 | 0 |
| Operating revenue | 231.38%28.4B | -2.49%8.66B | --0 | --0 | ---26.79B | --8.57B | --8.88B | --0 | --0 | --0 |
| Cost of revenue | 230.07%28.39B | -2.21%8.71B | 8.6B | 8.9B | ||||||
| Gross profit | 141.30%12.53M | -118.70%-44.95M | -30.34M | -20.55M | ||||||
| Operating expense | -596.63%-743.83M | -752.15%-353.06M | 0 | 48.08%3.19M | 145,953.26%515.57M | -37,174.65%-106.78M | 54.14M | 1K | -12.99%2.16M | -22.42%353K |
| Selling and administrative expenses | 109.85%73.15M | 16.89%42.03M | ---- | 48.08%3.19M | -28,693.77%-100.94M | 12,003.47%34.86M | 4,140.33%35.96M | -29.24%472K | -12.99%2.16M | -22.42%353K |
| -General and administrative expense | 109.85%73.15M | 16.89%42.03M | ---- | 48.08%3.19M | -28,693.77%-100.94M | 12,003.47%34.86M | 4,140.33%35.96M | -29.24%472K | -12.99%2.16M | -22.42%353K |
| Other operating expenses | -476.83%-816.98M | -2,273.23%-395.09M | ---- | ---- | ---- | ---141.63M | 2,243.87%18.18M | 29.24%-472K | ---- | ---- |
| Operating profit | 889.60%756.36M | 512.51%308.11M | 0 | -48.08%-3.19M | -125,789.24%-444.39M | 26,638.54%76.43M | -74.69M | -1K | 12.99%-2.16M | 22.42%-353K |
| Net non-operating interest income (expenses) | -102.89%-14.42M | -102.27%-14.24M | 0 | 50.66%7.71M | 1,453.29%28.83M | -679.05%-7.11M | -742.34%-7.04M | -100.11%-1K | 167.43%5.12M | 111.39%1.86M |
| Non-operating interest income | ---- | ---- | ---- | 50.66%7.71M | 19.77%2.22M | 64.47%2.02M | 68.16%1.84M | 73.32%1.62M | 167.43%5.12M | 111.39%1.86M |
| Non-operating interest expense | 102.89%14.42M | 102.27%14.24M | ---- | ---- | ---- | --7.11M | --7.04M | ---- | ---- | ---- |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1K | ---- | ---- |
| Other net income (expenses) | -77.98%-196.75M | -334.67%-251.71M | -74.25%126.23M | -19.18%329.71M | -46.18%-110.54M | -195.87%-57.91M | 47.54%141.67M | 184.82%490.27M | 309.60%407.95M | |
| Gain on sale of security | ---- | -4,763.97%-125.15M | ---- | ---- | ---- | ---2.86M | ---2.57M | ---- | ---- | ---- |
| Special income (charges) | -82.27%-197.7M | -123.85%-127.48M | ---- | --0 | -37.95%190.94M | -141.56%-108.47M | -175.41%-56.95M | --0 | 254.79%390.88M | 382.27%307.72M |
| -Less:Write off | 82.27%197.7M | 123.85%127.48M | ---- | --0 | 37.95%-190.94M | 141.56%108.47M | 175.41%56.95M | --0 | -254.79%-390.88M | -382.27%-307.72M |
| Other non-operating income (expenses) | 22.22%957K | -43.05%918K | ---- | 9,222.22%821K | 1.43%-1.79M | 171.88%783K | --1.61M | ---- | -100.15%-9K | -145.54%-1.81M |
| Income before tax | 1,422.82%545.2M | 130.19%42.16M | 0 | -73.49%130.75M | -120.97%-85.85M | 44.81%-41.22M | -327.05%-139.64M | -100.00%-1K | 185.25%493.23M | 310.84%409.45M |
| Income tax | 609.13%40.15M | 181.67%11.47M | 0 | 34.89%51.89M | 70.05%64.49M | -33.62%-7.89M | -1,372.10%-14.04M | 0 | 168.81%38.47M | 1,124.20%37.93M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 1,615.32%505.06M | 124.44%30.69M | 0 | -82.66%78.86M | -140.47%-150.35M | 51.54%-33.33M | -307.95%-125.6M | -100.00%-1K | 187.01%454.76M | 295.03%371.53M |
| Net income continuous operations | 1,615.32%505.06M | 124.44%30.69M | --0 | -82.66%78.86M | -140.47%-150.35M | 51.54%-33.33M | -307.95%-125.6M | -100.00%-1K | 187.01%454.76M | 295.03%371.53M |
| Noncontrolling interests | 296.59M | 35.45M | 0 | 0 | ||||||
| Net income attributable to the company | 1,170.39%713.53M | 110.33%25.94M | 0 | -82.66%78.86M | -202.16%-379.55M | 3.09%-66.66M | -307.95%-251.19M | -100.00%-1K | 187.01%454.76M | 295.03%371.53M |
| Preferred stock dividends | 76.00%-19.26M | -21.08M | -80.23M | |||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 1,801.64%208.47M | 131.96%14.5M | 0 | -82.66%78.86M | -98.35%6.14M | 82.19%-12.25M | -175.12%-45.37M | -100.00%-1K | 187.01%454.76M | 295.03%371.53M |
| Diluted earnings per share | 1,110.00%1.01 | 127.03%0.1 | 0 | -84.88%0.65 | -98.86%0.04 | 84.38%-0.1 | -164.91%-0.37 | -100.00%-0 | 186.17%4.3 | 290.76%3.51 |
| Basic earnings per share | 1,110.00%1.01 | 121.62%0.08 | 0 | -84.93%0.55 | 0 | 84.38%-0.1 | -174.00%-0.37 | -100.00%-0 | 173.15%3.65 | 260.33%2.95 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.